BioPharm News

Nov 10, 2017
By BioPharm International Editors
The authors of the study believe it could have significant implications for the discovery of new dermatological products for major diseases such as psoriasis.
Nov 10, 2017
By BioPharm International Editors
The company expects to commercially launch the new vaccine in the US in the first quarter of 2018.
Nov 10, 2017
By BioPharm International Editors
The company has introduced two new GMP vessel streams at its API manufacturing facility in Northumberland, UK that allows it to now offer fully integrated drug substance and drug product manufacturing.
Nov 10, 2017
By BioPharm International Editors
The EMA’s Committee for Medicinal Products for Human Use has recommended marketing authorization approval for AstraZeneca’s benralizumab, a monoclonal antibody for treating severe asthma.
Nov 10, 2017
By BioPharm International Editors
QuintilesIMS has changed its name to IQVIA to reflect its October 2016 merger with IMS Health.
Nov 10, 2017
By BioPharm International Editors
Two of the medicines recommended for approval are orphan drugs.
Nov 09, 2017
By BioPharm International Editors
The company has officially opened a local branch office in South Korean to support its existing business in the region.
Nov 09, 2017
By BioPharm International Editors
FDA is exploring ways to keep branded drug companies from using REMS to block the development of generic drugs.
Nov 07, 2017
By BioPharm International Editors
While most pharma companies are in partial production using generators, few are operating at 100% capacity.
Nov 07, 2017
By BioPharm International Editors
The debate continues over biosimilar naming, interchangeability, and patent protection, as well as lingering concerns in the medical community about the safety of switching patients to new therapies.
native1_300x100
lorem ipsum